WCBD

Ibogaine By David Dardashti Introduces New Algorithm for Depression Treatment

MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- In recent years, there has been a surge in clinical studies exploring the use of Ibogaine in treating depression. David Dardashti's Ibogaine has been leading ...
The Globe and Mail

Treatment-Resistant Depression Drugs Market 2032: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, Prevalence, Incidence, NDA Approvals, Therapies, and Companies by ...

Treatment-Resistant Depression companies working in the market are Navitor Pharmaceuticals, Supernus Pharmaceuti, Novartis, Relmada Therapeutics, Beckley Psytech, COMPASS Pathways, Axsome Therapeutics ...
Medscape

Joint APA-ACOG Algorithms for Treatment of Depression During Pregnancy

A groundbreaking collaboration provides useful advice on a clinically challenging problem. Depression is common in women during the childbearing years, and psychiatrists and obstetricians alike can ...
Psychology Today

TMS Outperforms Medication in Study of Treatment-Resistant Depression

Transcranial magnetic stimulation (TMS, or "rTMS" for "repetitive TMS") received an indication for treating major depressive disorder in 2008. Since then, research and clinical experience with TMS has ...
Mena FN

Postpartum Depression Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline GH Research, Reunion Neuroscience, Lipocine, Brii Biosciences ...

"Postpartum Depression Pipeline"DelveInsight's,“Postpartum Depression - Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Postpartum ...
Labroots

Using an AI algorithm to distinguish between major depressive disorder and bipolar disorder

A study published in the Journal of Affective Disorders proposes a novel, fully automated artificial intelligence (AI) algorithm leveraging ExtraTrees (ET) forests to distinguish patients with major ...